Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Segmental Reporting Restatement Document

17 Apr 2019 11:20

RNS Number : 5059W
Royal Bank of Scotland Group PLC
17 April 2019
 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segmental Reporting Restatement

Document

 

April 2019

 

 

 

 

 

 

 

The Royal Bank of Scotland Group plc

 

Overview of business re-segmentation

This announcement sets out changes to RBS's operating segments and consequent changes in results presentation. The announcement contains re-presented financial results for the year ended 31 December 2018 and, is presented to aid comparison of RBS's quarter ended 31 March 2019 results with prior periods. Re-presented financial information for the quarters ended 31 December 2018 and 31 March 2018 are included.

 

Segmental reorganisation

RBS continues to deliver on its plan to build a strong, simple and fair bank for both customers and shareholders. To support this, the following previously reported operating segments are now realigned, with comparatives re-presented:

 

· Effective from 1 January 2019, Business Banking has been transferred from UK Personal and Business Banking (UK PBB) to Commercial Banking as the nature of the business, including distribution channels, products and customers, are more closely aligned to the Commercial Banking (CB) business. Concurrent with the transfer, UK PBB has been renamed to UK Personal Banking (UK PB) and the previous franchise combining UK PBB (now UK PB) and Ulster Bank RoI has been renamed Personal & Ulster. The Commercial & Private Banking franchise has also been renamed to Commercial & Private.

 

Quarter ended 31 March 2019 results

RBS's results for the quarter ended 31 March 2019 will be announced on Friday 26 April 2019. These results will be reported on the new structure and reporting basis as described above.

 

In conjunction with this Segmental Reporting Restatement Document, a financial supplement showing re-presented financial information for the last nine quarters is available at www.rbs.com/results. 

 

Forward-looking statements

This document contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'expect', 'estimate', 'project', 'anticipate', 'commit', 'believe', 'should', 'intend', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'may', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as RBSG's future economic results, business plans and current strategies. In particular, this document includes forward-looking statements relating to RBSG in respect of, but not limited to: its regulatory capital position and related requirements, its financial position, profitability and financial performance (including financial, capital and operational targets), its access to adequate sources of liquidity and funding, increasing competition from new incumbents and disruptive technologies, its impairment losses and credit exposures under certain specified scenarios, substantial regulation and oversight, ongoing legal, regulatory and governmental actions and investigations, LIBOR, EURIBOR and other benchmark reform and RBSG's exposure to economic and political risks (including with respect to Brexit and climate change), operational risk, conduct risk, cyber and IT risk and credit rating risk. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBSG's actual results are discussed in RBSG's UK 2018 Annual Report and Accounts (ARA) and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBSG's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this document speak only as of the date of this document and RBSG does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

Document roadmap

Pages 2 to 5 of this document show the income statement, selected balance sheet line items and key metrics for the new reportable segments for the year and quarter ended 31 December 2018 and for the quarter ended 31 March 2018. The Re-segmentation reconciliation Appendix - summarises how Business Banking area is allocated to the reportable operating segment Commercial Banking.

 

For further information contact:

 

Alexander Holcroft

Investor Relations

+44 (0) 207 672 1982

 

Group Media Centre

+44 (0)131 523 4205

Re-presented customer segments

 

 

Year ended 31 December 2018

 

Personal & Ulster

Commercial & Private

 

UK Personal

Ulster Bank

Commercial

Private

RBS

NatWest

Central items

Total

 

Banking (1)

RoI

Banking

Banking

International

Markets

& other (2)

RBS

 

Income statement

£m

£m

£m

£m

£m

£m

£m

£m

 

 

Net interest income

4,283 

444 

2,855 

518 

466 

112 

(22)

8,656 

 

Non-interest income

771 

166 

1,747 

257 

128 

1,238 

347 

4,654 

 

Own credit adjustments

92 

92 

 

 

Total income

5,054 

610 

4,602 

775 

594 

1,442 

325 

13,402 

 

 

Direct expenses

 

- staff

(698)

(202)

(739)

(161)

(102)

(557)

(1,190)

(3,649)

 

- other

(266)

(103)

(255)

(66)

(67)

(241)

(2,712)

(3,710)

 

Indirect expenses

(1,464)

(185)

(1,294)

(229)

(91)

(415)

3,678 

 

Strategic costs

 

- direct

(41)

(2)

(33)

(3)

(195)

(730)

(1,004)

 

- indirect

(185)

(20)

(122)

(21)

(6)

(43)

397 

 

Litigation and conduct costs

(213)

(71)

(44)

(1)

(153)

(809)

(1,282)

 

 

Operating expenses

(2,867)

(583)

(2,487)

(478)

(260)

(1,604)

(1,366)

(9,645)

 

 

Operating profit/(loss) before impairment (losses)/releases

2,187 

27 

2,115 

297 

334 

(162)

(1,041)

3,757 

 

Impairment (losses)/releases

(339)

(15)

(147)

92 

(398)

 

 

Operating profit/(loss)

1,848 

12 

1,968 

303 

336 

(70)

(1,038)

3,359 

 

 

Key metrics

Return on equity (3)

24.7%

0.5%

12.1%

15.4%

24.4%

(2.0%)

nm

4.8%

Net interest margin

2.67%

1.79%

1.96%

2.52%

1.71%

0.40%

nm

1.98%

Cost:income ratio (4)

56.7%

95.6%

52.8%

61.7%

43.8%

111.2%

nm

71.7%

Loan impairment rate

0.23%

0.08%

0.14%

nm

nm

nm

nm

0.13%

As at 31 December 2018

Capital and balance sheet

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

171.0 

25.2 

166.4 

22.0 

28.4 

244.5 

36.7 

694.2 

Funded assets (5)

171.0 

25.2 

166.4 

22.0 

28.4 

111.4 

36.5 

560.9 

Net loans to customers - amortised cost

148.9 

18.8 

101.4 

14.3 

13.3 

8.4 

305.1 

Impairment provisions

(1.1)

(0.8)

(1.3)

(0.1)

(3.3)

Customer deposits

145.3 

18.0 

134.4 

28.4 

27.5 

2.6 

4.7 

360.9 

Risk-weighted assets (RWAs)

34.3 

14.7 

78.4 

9.4 

6.9 

44.9 

0.1 

188.7 

RWA equivalent (RWAes)

35.5 

14.7 

79.7 

9.5 

6.9 

50.0 

0.2 

196.5 

Employee numbers (FTEs - thousands) (6)

21.7 

3.1 

10.3 

1.9 

1.7 

4.8 

23.6 

67.1 

For notes to this table refer to page 5.

 

Re-presented customer segments

 

Quarter ended 31 December 2018

Personal & Ulster

Commercial & Private

 UK Personal

Ulster Bank

Commercial

Private

RBS

NatWest

Central items

Total

Banking (1)

RoI

Banking

Banking

International

Markets

& other (2)

RBS

Income statement

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

1,061 

110 

724 

133 

123 

30 

(5)

2,176 

Non-interest income

185 

37 

392 

65 

32 

89 

49 

849 

Own credit adjustments

33 

33 

Total income

1,246 

147 

1,116 

198 

155 

152 

44 

3,058 

Direct expenses

- staff

(166)

(53)

(185)

(39)

(25)

(128)

(263)

(859)

- other

(80)

(27)

(77)

(22)

(22)

(65)

(870)

(1,163)

Indirect expenses

(414)

(52)

(403)

(72)

(35)

(123)

1,099 

Strategic costs

- direct

(27)

(3)

(5)

(1)

(89)

(230)

(355)

- indirect

(63)

(12)

(57)

(10)

(2)

(22)

166 

Litigation and conduct costs

(7)

(17)

(37)

(1)

(28)

(2)

(92)

Operating expenses

(757)

(164)

(764)

(143)

(86)

(455)

(100)

(2,469)

Operating profit/(loss) before impairment (losses)/releases

489 

(17)

352 

55 

69 

(303)

(56)

589 

Impairment (losses)/releases

(142)

19 

(5)

100 

(17)

Operating profit/(loss)

347 

347 

63 

71 

(203)

(55)

572 

Key metrics

Return on equity (3)

17.2%

0.4%

8.3%

12.3%

20.0%

(9.2%)

nm

3.5%

Net interest margin

2.60%

1.73%

1.96%

2.49%

1.81%

0.39%

nm

1.95%

Cost:income ratio (4)

60.8%

111.6%

67.5%

72.2%

55.5%

299.3%

nm

80.5%

Loan impairment rate

0.38%

(0.39%)

0.02%

nm

nm

nm

nm

0.02%

For the notes to this table refer to page 5.

 

Re-presented customer segments

Quarter ended 31 March 2018

Personal & Ulster

Commercial & Private

UK Personal

Ulster Bank

Commercial

Private

RBS

NatWest

Central items

Total

Banking (1)

RoI

Banking

Banking

International

Markets

& other (2)

RBS

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

1,068 

106 

683 

123 

104 

36 

26 

2,146 

Non-interest income

230 

40 

475 

61 

33 

380 

(84)

1,135 

Own credit adjustments

21 

21 

Total income

1,298 

146 

1,158 

184 

137 

437 

(58)

3,302 

Direct expenses

- staff

(178)

(49)

(188)

(43)

(24)

(165)

(317)

(964)

- other

(65)

(19)

(47)

(14)

(15)

(53)

(606)

(819)

Indirect expenses

(374)

(47)

(311)

(55)

(20)

(102)

909 

Strategic costs

- direct

(7)

(1)

(6)

(1)

(17)

(177)

(209)

- indirect

(61)

(3)

(42)

(8)

(1)

(6)

121 

Litigation and conduct costs

(1)

(9)

(1)

(6)

(3)

(19)

Operating expenses

(686)

(128)

(595)

(121)

(59)

(349)

(73)

(2,011)

Operating profit/(loss) before impairment (losses)/releases

612 

18 

563 

63 

78 

88 

(131)

1,291 

Impairment (losses)/releases

(68)

(8)

(12)

(1)

(78)

Operating profit/(loss)

544 

10 

551 

62 

78 

97 

(129)

1,213 

For the notes to this table refer to page 5.

 

Re-presented customer segments

 

Quarter ended 31 March 2018

Personal & Ulster

Commercial & Private

UK Personal

Ulster Bank

 Commercial

Private

RBS

NatWest

Central items

 Total

Key metrics

Banking (1)

RoI

Banking

Banking

International

Markets

& other (2)

RBS

Return on equity (3)

29.9%

1.6%

13.6%

12.5%

23.2%

2.0%

nm

9.3%

Net interest margin

2.73%

1.80%

1.91%

2.51%

1.57%

0.54%

nm

2.04%

Cost:income ratio (4)

52.9%

87.7%

50.0%

65.8%

43.1%

79.9%

nm

60.5%

Loan impairment rate

0.18%

0.16%

0.05%

nm

nm

nm

nm

nm

As at 31 March 2018

Capital and balance sheet

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

166.3 

23.4 

165.6 

20.4 

28.0 

283.8 

51.0 

738.5 

Funded assets (5)

166.3 

23.3 

165.5 

20.4 

28.0 

135.2 

50.0 

588.7 

Net loans to customers - amortised cost (£bn)

145.9 

19.0 

102.9 

13.7 

13.1 

9.4 

(0.2)

303.8 

Impairment provisions

(1.3)

(1.2)

(1.5)

(0.1)

(0.2)

0.1 

(4.2)

Customer deposits

142.9 

16.4 

131.1 

25.3 

26.9 

3.8 

8.1 

354.5 

Risk-weighted assets (RWAs)

31.5 

16.9 

84.3 

9.4 

7.0 

53.1 

0.5 

202.7 

RWA equivalent (RWAes)

32.2 

17.4 

88.9 

9.4 

7.0 

56.5 

0.9 

212.3 

Employee numbers (FTEs - thousands) (6)

24.5 

3.0 

10.7 

1.9 

1.7 

5.7 

23.4 

70.9 

nm = not meaningful

 

Notes:

(1)

(2)

Reportable operating segment UK Personal and Business Banking renamed to UK Personal Banking to reflect re-segmentation.

Central items include unallocated transactions which principally comprise volatile items under IFRS and RMBS related charges.

(3)

RBS's CET 1 target is approximately 14% but for the purposes of computing segmental return on equity (ROE), to better reflect the differential drivers of capital usage, segmental operating profit after tax and adjusted for preference share dividends is divided by average notional equity allocated at different rates of 14% (Ulster Bank RoI), 12% (Commercial Banking), 13.5% (Private Banking), 16% (RBS International) and 15% for all other segments, of the monthly average of segmental risk-weighted assets equivalents (RWAes) incorporating the effect of capital deductions. RBS return on equity is calculated using profit for the period attributable to ordinary shareholders over tangible net asset value.

(4)

Operating lease depreciation included in income for the year ended 31 December 2018 - £121 million; Q4 2018 - £32 million; Q1 2018 - £31 million.

(5)

Funded assets exclude derivative assets.

(6)

On 1 January 2018, 7,600 employees on a FTE basis were transferred from Central items to UK Personal Banking, 200 to Ulster Bank RoI, 3,700 to Commercial Banking and 400 to Private Banking.

 

 

 

 

 

 

 

 

 

Appendix

 

Re-segmentation reconciliations

 

UK Personal Banking (operating segment within the Personal & Ulster franchise)

 

Year ended

Quarter ended

Quarter ended

31 December 2018

31 December 2018

31 March 2018

Previously

Previously

Previously

reported

To

Total

reported

To

Total

reported

To

Total

UK PBB

CB

UK PB(1)

UK PBB

CB

UK PB(1)

UK PBB

CB

UK PB(1)

Income statement

£m

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

5,098 

(815)

4,283 

1,267 

(206)

1,061 

1,259 

(191)

1,068 

Non-interest income

1,184 

(413)

771 

290 

(105)

185 

332 

(102)

230 

Total income

6,282 

(1,228)

5,054 

1,557 

(311)

1,246 

1,591 

(293)

1,298 

Direct expenses

- staff

(890)

192 

(698)

(208)

42 

(166)

(229)

51 

(178)

- other

(300)

34 

(266)

(93)

13 

(80)

(70)

(65)

Indirect expenses

(1,801)

337 

(1,464)

(522)

108 

(414)

(456)

82 

(374)

Strategic costs

- direct

(54)

13 

(41)

(28)

(27)

(12)

(7)

- indirect

(221)

36 

(185)

(84)

21 

(63)

(68)

(61)

Litigation and conduct costs

(216)

(213)

(6)

(1)

(7)

(1)

(1)

Operating expenses

(3,482)

615 

(2,867)

(941)

184 

(757)

(836)

150 

(686)

Operating profit before impairment

losses

2,800 

(613)

2,187 

616 

(127)

489 

755 

(143)

612 

Impairment losses

(342)

(339)

(125)

(17)

(142)

(57)

(11)

(68)

Operating profit

2,458 

(610)

1,848 

491 

(144)

347 

698 

(154)

544 

Key metrics

Return on equity (2)

24.3%

0.4%

24.7%

18.6%

(1.4%)

17.2%

27.9%

2.0%

29.9%

Net interest margin

2.78%

(0.11%)

2.67%

2.73%

(0.13%)

2.60%

2.81%

(0.08%)

2.73%

Cost:income ratio

55.4%

1.3%

56.7%

60.4%

0.4%

60.8%

52.5%

0.4%

52.9%

Loan impairment rate

0.21%

0.02%

0.23%

0.31%

0.07%

0.38%

0.14%

0.04%

0.18%

 

31 December 2018

31 March 2018

Previously

Previously

reported

To

Total

reported

To

Total

UK PBB

CB

UK PB(1)

UK PBB

CB

UK PB(1)

Capital and balance sheet

£bn

£bn

£bn

£bn

£bn

£bn

Loans to customers - amortised cost

163.7 

(13.7)

150.0 

162.1 

(14.9)

147.2 

Impairment provisions

(1.4)

0.3 

(1.1)

(1.6)

0.3 

(1.3)

Net loans to customers - amortised cost

162.3 

(13.4)

148.9 

160.5 

(14.6)

145.9 

Funded assets

194.2 

(23.2)

171.0 

190.3 

(24.0)

166.3 

Customer deposits

184.1 

(38.8)

145.3 

180.3 

(37.4)

142.9 

Loan:deposit ratio

88%

14%

102%

89%

13%

102%

Risk-weighted assets

45.1 

(10.8)

34.3 

43.4 

(11.9)

31.5 

 

Notes:

(1)

Reportable operating segment UK Personal and Business Banking renamed to UK Personal Banking to reflect re-segmentation.

(2)

Return on equity is based on segmental operating profit after tax adjusted for preference dividends divided by average notional equity based on 15% of the monthly average of segmental Risk-weighted assets equivalents (RWAes), incorporating the effect of capital deductions, assuming 28% tax rate. Return on equity is calculated using profit for the period attributable to ordinary shareholders.

 

Commercial Banking (operating segment within the Commercial & Private franchise)

 

Year ended

Quarter ended

Quarter ended

31 December 2018

31 December 2018

31 March 2018

Previously

From

Total

Previously

From

Total

Previously

From

Total

reported CB

UK PB

CB

reported CB

UK PB

CB

reported CB

UK PB

CB

Income statement

£m

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

2,040 

815 

2,855 

518 

206 

724 

492 

191 

683 

Non-interest income

1,334 

413 

1,747 

287 

105 

392 

373 

102 

475 

Total income

3,374 

1,228 

4,602 

805 

311 

1,116 

865 

293 

1,158 

Direct expenses

- staff

(547)

(192)

(739)

(143)

(42)

(185)

(137)

(51)

(188)

- other

(221)

(34)

(255)

(64)

(13)

(77)

(42)

(5)

(47)

Indirect expenses

(957)

(337)

(1,294)

(295)

(108)

(403)

(229)

(82)

(311)

Strategic costs

- direct

(20)

(13)

(33)

(4)

(1)

(5)

(1)

(5)

(6)

- indirect

(86)

(36)

(122)

(36)

(21)

(57)

(35)

(7)

(42)

Litigation and conduct costs

(41)

(3)

(44)

(38)

(37)

(1)

(1)

Operating expenses

(1,872)

(615)

(2,487)

(580)

(184)

(764)

(445)

(150)

(595)

Operating profit before impairment

(losses)/releases

1,502 

613 

2,115 

225 

127 

352 

420 

143 

563 

Impairment (losses)/releases

(144)

(3)

(147)

(22)

17 

(5)

(23)

11 

(12)

Operating profit

1,358 

610 

1,968 

203 

144 

347 

397 

154 

551 

Key metrics

Return on equity (1)

10.2%

1.9%

12.1%

5.5%

2.8%

8.3%

12.2%

1.4%

13.6%

Net interest margin

1.67%

0.29%

1.96%

1.66%

0.30%

1.96%

1.64%

0.27%

1.91%

Cost:income ratio

53.8%

(1.0%)

52.8%

70.9%

(3.4%)

67.5%

49.6%

0.4%

50.0%

Loan impairment rate

0.16%

0.02%

0.14%

0.10%

0.08%

0.02%

0.10%

0.05%

0.05%

 

31 December 2018

31 March 2018

Previously

From

Total

Previously

From

Total

reported CB

UK PB

CB

reported CB

UK PB

CB

Capital and balance sheet

£bn

£bn

£bn

£bn

£bn

£bn

Loans to customers - amortised cost

89.0 

13.7 

102.7 

89.5 

14.9 

104.4 

Impairment provisions

(1.0)

(0.3)

(1.3)

(1.2)

(0.3)

(1.5)

Net loans to customers - amortised cost

88.0 

13.4 

101.4 

88.3 

14.6 

102.9 

Funded assets

143.2 

23.2 

166.4 

141.5 

24.0 

165.5 

Customer deposits

95.6 

38.8 

134.4 

93.7 

37.4 

131.1 

Loan:deposit ratio

92%

(16%)

76%

94%

(14%)

80%

Risk-weighted assets

67.6 

10.8 

78.4 

72.4 

11.9 

84.3 

 

Note:

(1)

Return on equity is based on segmental operating profit after tax adjusted for preference dividends divided by average notional equity based on 11% of the monthly average of segmental Risk-weighted assets equivalents (RWAes), incorporating the effect of capital deductions, assuming 28% tax rate. Return on equity is calculated using profit for the period attributable to ordinary shareholders.

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGUUGCUPBGUM
Date   Source Headline
17th Mar 20205:24 pmRNSDirectorate Change
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20208:30 amRNSMorgan Stanley European Financials Conference
16th Mar 20205:14 pmRNSNatWest Markets N.V. 2019 ARA
10th Mar 20204:51 pmRNSDirector/PDMR Shareholding
2nd Mar 20202:34 pmRNSDirector/PDMR Shareholding
28th Feb 20204:29 pmRNSCorrection of Dividend Declaration
28th Feb 20201:58 pmRNSTotal Voting Rights and Capital
28th Feb 20207:00 amRNSFiling of Annual Report on Form 20-F with US SEC
27th Feb 20209:55 amRNSBlock Listing Cancellation
24th Feb 202012:40 pmRNSDividend Declaration
20th Feb 20204:10 pmRNSHolding(s) in Company
14th Feb 20203:58 pmRNSRBSG ENTM Publication of Suppl.Prospcts
14th Feb 20207:01 amRNSAnnual Financial Report
14th Feb 20207:00 amRNSFinal Results
31st Jan 20202:12 pmRNSTotal Voting Rights and Capital
30th Jan 20203:57 pmRNSDirector/PDMR Shareholding
16th Jan 20202:08 pmRNSForm 8.3 - Accesso Technology Group plc
2nd Jan 20201:58 pmRNSForm 8.3 - Accesso Technology Group plc
31st Dec 20191:10 pmRNSDirector/PDMR Shareholding
31st Dec 201911:20 amRNSTotal Voting Rights and Capital
30th Dec 20193:02 pmRNSForm 8.3 - Accesso Technology Group plc
20th Dec 20197:00 amRNSPublication of Suppl.Prospcts replacement
19th Dec 20195:40 pmRNSPublication of Suppl.Prospcts
19th Dec 20197:00 amRNSNatWest Markets Change in Executive Directors
16th Dec 20195:47 pmRNS2019 Bank of England stress test results
4th Dec 201912:34 pmRNSForm 8.3 - Accesso Technology Group plc
2nd Dec 20195:34 pmRNSPublication of Suppl.Prospcts
29th Nov 20192:20 pmRNSDirector/PDMR Shareholding
29th Nov 20191:28 pmRNSAnnouncement of NatWest Markets N.V. Transfer
29th Nov 201912:01 pmRNSTotal Voting Rights and Capital
27th Nov 201911:56 amRNSDividend Declaration
21st Nov 20196:26 pmRNSPublication of a Prospectus
21st Nov 201910:45 amRNSReduction in Pillar 2A capital requirements
14th Nov 201911:23 amRNSPublication of Final Terms
13th Nov 20193:00 pmRNSForm 8.3 - Accesso Technology Group plc
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
1st Nov 20194:12 pmRNSDirector/PDMR Shareholding
31st Oct 20193:30 pmRNSDirector/PDMR Shareholding
31st Oct 20192:08 pmRNSTotal Voting Rights and Capital
30th Oct 20199:38 amRNSRBSG pricing of US$750mn of Subordinated Notes
25th Oct 20195:22 pmRNSPublication of Suppl.Prospcts
24th Oct 20197:00 amRNSQ3 Interim Management Statement
16th Oct 20192:54 pmRNSForm 8.3 - Accesso Technology Group plc
8th Oct 201911:35 amRNSBlock Listing Six Monthly Return
3rd Oct 20191:08 pmRNSPublication of Final Terms
1st Oct 20195:29 pmRNSDirector/PDMR Shareholding
30th Sep 20193:28 pmRNSTotal Voting Rights
24th Sep 20198:30 amRNSBank of America Merrill Lynch Annual Conference

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.